feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

trending

Andaman earthquake strikes sea

trending

SEBI cautions digital gold investments

trending

Mumbai stray dog shelter shortage

trending

Djokovic withdraws from ATP Finals

trending

Real Madrid faces Rayo Vallecano

trending

Man City vs Liverpool

trending

Arsenal leads Premier League race

trending

PSG aims to stretch unbeaten

trending

Thuram pushes Inter vs Lazio

Home / Health / Nobel Laureate James Watson, DNA Pioneer, Dies at 97

Nobel Laureate James Watson, DNA Pioneer, Dies at 97

11 Nov

•

Summary

  • James Watson, co-discoverer of DNA's double-helix structure, dies at 97
  • First clinical trials of pig kidney transplants begin in New York
  • Concerns raised over increasing use of AI in medical diagnostics
Nobel Laureate James Watson, DNA Pioneer, Dies at 97

Last month, the world bid farewell to a pioneering scientist who fundamentally shaped our understanding of the human body. James Watson, the Nobel laureate who co-discovered the double-helix structure of DNA, passed away on November 8th at the age of 97. Watson and his colleague Francis Crick were awarded the 1962 Nobel Prize in Physiology or Medicine for their groundbreaking work, which laid the foundation for modern biology and opened the door to revolutionary advancements in fields like medicine, forensics, and genetics.

In other medical news, the first clinical trial of pig kidney transplants has begun in New York. United Therapeutics, a company producing gene-edited pig kidneys, announced that the initial transplant was successfully performed at NYU Langone Health. This marks a significant step forward in the quest for animal-to-human organ transplants, which could revolutionize the field of organ transplantation worldwide.

However, the increasing use of AI in medical diagnostics is also raising concerns. Tech giants like Microsoft and Meta Platforms have launched teams targeting AI-powered medical breakthroughs, raising fears about the potential for biases and risky behaviors. Experts caution that adequate human oversight is crucial as these AI-driven initiatives continue to expand in the healthcare sector.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
James Watson, along with Francis Crick, co-discovered the double-helix structure of DNA, a pivotal breakthrough that laid the foundation for modern biology and opened the door to revolutionary advancements in fields like medicine, forensics, and genetics.
The first clinical trials of pig kidney transplants are underway in New York, with the initial transplant successfully performed at NYU Langone Health by the company United Therapeutics.
The increasing use of AI in medical diagnostics is raising concerns, as tech giants like Microsoft and Meta Platforms have launched teams targeting AI-powered medical breakthroughs. Experts caution that adequate human oversight is crucial as these AI-driven initiatives continue to expand in the healthcare sector.

Read more news on

Healthside-arrowMicrosoftside-arrow

Advertisement

Advertisement

You may also like

AI Breakthrough Unlocks Faster Antibody Design for Drugs

1 day ago • 5 reads

article image

Microsoft Soars on AI Boost: Guggenheim Upgrades to Buy

28 Oct • 49 reads

article image

Acclaimed Director Kelly Reichardt Ventures into Unexpected Territory with "The Mastermind"

18 Oct • 100 reads

article image

Gwyneth Paltrow's Daughter Embraces Opportunities, Maintains Grounded Approach

18 Oct • 53 reads

article image

FDA Slaps Strictest Warning on J&J's Cancer Drug Carvykti

14 Oct • 91 reads

article image